Study Report HIV Prevention: One Arm, Open Label, Prospective, Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Scale Up of.

Slides:



Advertisements
Similar presentations
National AIDS/STD Control Programme Ministry of Health, Kenya and Ministry of Medical Services, Kenya Pilot Study of the Shang Ring: A Novel Male Circumcision.
Advertisements

Prof. Mufuta Tshimanga Co-Principal Investigator
PrePexTM: A New Device for Male Circumcision
Implementation of a Surgical Safety Check List
Models to increase Volumes and Efficiency in Zimbabwe’s Male Circumcision program K. Hatzold 1, C. Samkange 2, E. Fusire 3, G.S. Dendere 4, K. Kaseke 1,
Originally developed by Susan Warman, BN., Helen Gourlay,BN/MN.,and Janet Walker, BN. January 1997 Revised Dec 2005 by Nancy Schuttenbeld -Acute Pain Nurse.
CBER Isolagen Therapy (IT) BLA FDA Clinical Review Agnes Lim, MD Yao-Yao Zhu, MD, PhD DCEPT/OCTGT/CBER, FDA October 9, 2009 Advisory Committee Meeting.
Male Circumcision and HIV Infection
Medical Male Circumcision Recruiter Discussion Guide
Dr. Tim Mastro for the Study Team AIDS 2014 Melbourne, Australia
The Acceptability and Safety of the Shang Ring for Adult Male Circumcision in Rakai, Uganda. Godfrey Kigozi, Richard Musoke, Stephen Watya, Nehemiah Kighoma,
Best Practices for Pressure Ulcers to Promote Uncomplicated Healing.
Comparison Study of EIMC Devices and Pilot Implementation in Botswana Rebeca M. Plank, MD MPH Brigham and Women’s Hospital / Botswana-Harvard School of.
Islamic University of Gaza Faculty of Nursing
Put a Ring on it: How the Shang Ring Might Accelerate MC Programs
Emmanuel Njeuhmeli, MD, MPH, MBA
Experience with PrePex Device Use with Adults and Adolescents in Pilot Implementation and Active Surveillance from Zimbabwe, Zambia and South Africa Karin.
S urgical P re A dmission R eview C linics (SPARC) Truc Nguyen Pharmacy Surgical Team Leader CMH Pharmacy.
Acceptability of early infant male circumcision & experiences with the AccuCirc device in Zimbabwe Mavhu W, Ncube G, Hatzold K, Weiss HA, Mugurungi O,
AIDS 2014, Melbourne, Australia July 25th, 2014
A Prospective Cohort Study JD Reinhardt, X Zhang, JE Gosney & J Li Long-term effectiveness and efficiency of rehabilitation services delivery for victims.
InFUSE ™ Bone Graft / LT-CAGE ™ Lumbar Tapered Fusion Device IDE Clinical Results G Hallett H. Mathews, M.D. Richmond, Virginia.
Presenter : Dr T. G. Nematadzira on behalf of The IMPAACT PROMISE 1077BF/1077FF Team Efficacy and Safety of Two Strategies to Prevent Perinatal HIV Transmission.
Surgical Site Infection and its Prevention T R Wilson.
Summarising Male Circumcision Efficacy: Results of the three randomised clinical trials Neil A Martinson Perinatal HIV Research Unit.
Conservative Sharp Debridement Nursing Care Responsibilities (Physical Therapy Too) Patricia Gill, MSN, RN, CWON, CHRN.
DHHS / FDA / CDRH 1 Circulatory Support Devices Panel Tuesday, September 11, 2001 CoSeal® Surgical Sealant P
 Rwanda national goal: VMMC to 2 million men in 2 years to decrease HIV incidence by 50%; attainable only if task shifting is possible to nurses, as.
Introduction to Devices for VMMC: Potential to Accelerate Scale-up, Approval Processes, and Status of Clinical Trials Jason Reed, MD, MPH Sr. Technical.
Design: A randomized, prospective, double-blind cohort followed for 16 weeks RenehaVis Original Study 50 DMW 50 HMW 50 LMW 50 Placebo.
Sandeep Bagla, MD Cardiovascular & Interventional Radiology Inova Alexandria Hospital.
Disclosure Information… The following relationships exist related to this presentation: Michael R. Lassen Consulting Feessanofi-aventis Modest Level Dirk.
Scaling-up male circumcision programmes in the Eastern and Southern Africa Region Country update meeting HIV Testing and Counseling and Male Circumcision.
The Shang Ring vs Conventional Surgical Techniques: an RCT in Kenya and Zambia Session TUAC04 Male Circumcision: Strategies and Impact AIDS 2012: Tuesday,
Plymouth Health Community NICE Guidance Implementation Group Workshop Two: Debriding agents and specialist wound care clinics. Pressure ulcer risk assessment.
Atraumatic Circumcision Device (AccuCirc) Overview
12/6/20151 Cochlear implants in the older patient Mark Pyle MD Professor of surgery and Academic Vice Chair Division of Otolaryngology.
1 Study Design Issues and Considerations in HUS Trials Yan Wang, Ph.D. Statistical Reviewer Division of Biometrics IV OB/OTS/CDER/FDA April 12, 2007.
Advances in Task Sharing: Findings from Uganda & Sierra Leone Julia Byington Programme Advisor, Marie Stopes International.
Background Methods Use of free to use social media to disseminate information in healthcare has increased, but evidence of the effect of this effort is.
EngenderHealth’s Work on Male Circumcision
: Intermittent Neurogenic Claudication Aperius ® Percutaneous Interspinous Spacer F. Collignon, P. Fransen, D Morelli, N. Craig, J. Van Meirhaeghe For.
1 5 th World Conference on Virology, December th 2015, Atlanta,USA Chaste KARANGWA 1, Eugene RUGIRA 1, Placidie MUGWANEZA 1, Helene Badini 3, Fabian.
EVEREST II Study Design Multicenter Randomized in a 2:1 ratio to either percutaneous or conventional surgery for the repair or replacement of the mitral.
TF_Arusha_Jun10/1 Framework for Evaluation of Male Circumcision Devices Tim Farley Department of Reproductive Health and Research World Health Organization.
mild Decompression for the Treatment of Lumbar Spinal Stenosis
ASCEND-HF Acute Study of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure Duke Heart Failure Research Pager:
Beliefs about Male Circumcision among Men from a Traditionally Non- Circumcising Community in Rural Western Kenya, Adega, A, Burmen, B, Mutai,
CC F Copyright 2007 Conceptus Incorporated. All rights reserved. 9/16/2008 What is the Essure Procedure? First and only FDA-approved transcervical.
Elijah Odoyo-June 1,3, John Rogers 2, Walter Jaoko 1,3, Robert C. Bailey 1, 2 1 Nyanza Reproductive Health Society 2 University of Illinois at Chicago.
Mobile Male Circumcision Services in the Lake Victoria Islands of Kagera, Tanzania: Mobile Male Circumcision Services in the Lake Victoria Islands of Kagera,
The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda (WEAC101) Godfrey Kigozi Rakai Health Sciences Program 4th IAS.
HOW CAN Dressilk® IMPROVE SUPERFICIAL WOUND MANAGEMENT?
Understanding community needs when providing VMMC services to adolescents: A case of a remote rural village in Zimbabwe. Dr J Hove ZACH.
Implementation of a Surgical Safety Check List
Figure 1. Onset of PIV catheter complications
On behalf of The MTN-020/ASPIRE Study Team
WEPDC0104 Barriers to and facilitators of VMMC uptake among older men aged years in Nyanza Region, Western Kenya (the TASCO study) Kawango Agot1,
Evaluation of the AccuCirc Device for Early Infant Male Circumcision in Kisumu, Kenya: Uptake and Safety Irene Nyaboke1, Valentine Pengo1, Mildred Adhiambo1,
Background Over PCIs per year for stable angina
For the CLOSE-UP study group
Axel Linke University of Leipzig Heart Center, Leipzig, Germany
Emmanuel Njeuhmeli, MD, MPH, MBA
Rhematoid Rthritis Respiratory disorders
Hallett H. Mathews, M.D. Richmond, Virginia
Voluntary Medical Male Circumcision (VMMC) Device Evaluations
Abstract number: A Profile of Adverse Events in the Largest Voluntary Medical Male Circumcision Program in Mozambique 2009–2017 by: Sérgio.
The Research Question Lateral epicondylosis (tennis elbow) is common, debilitating and often refractory to routine care. Prolotherapy, an injection-based.
CIC Prep Questions Education and Research
Safety and Efficacy of Mapracorat Ophthalmic Suspension in the Treatment of Inflammation Following Cataract Surgery: Adaptive Design Study Timothy L.
Presentation transcript:

Study Report HIV Prevention: One Arm, Open Label, Prospective, Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Scale Up of Non-Surgical Circumcision when Performed by Nurses in Resource Limited Settings MUTABAZI Vincent Rwanda Ministry of Health ICASA Conference 4-8 th Dec 2011

Background Rwanda done over 1000 PrePex MC according to WHO framework Rwanda PrePex clinical studies to date: 1.Safety study –physician’s PrePex MC 2.Randomized controlled study comparing PrePex MC to surgical MC 3.Nurses PrePex MC cohort study (current) PrePex is used routinely in Rwanda for MC by physicians and nurses Scale up planned to start Q – objective of 2M MC in 2 years

Background PrePex Non Surgical – No sterile settings – No injected anesthesia – Bloodless procedure – No sutures

Study Design 590 adult male subjects 10 nurses with no experience in MC or PrePex were formally trained, and paired to 5 PrePex teams Intervention – PrePex MC Follow up period of up to 8 weeks l

Methods Placement Procedure 7 days later Removal Procedure a - Sizingb – Applying Anesthetic cream c – Marking Lined – Placing Devicee - Discharging a – Removing Necrotic foreskin b – Piercing Elastic Ring c – Extracting Inner Ring d – Dressing the wound

Primary Endpoint To validate the safety of the PrePex MC when performed by nurses, by means of rate of incidence of Adverse Events and Device- related Adverse Events

Secondary Endpoints To validate Efficacy by means of: Rate of complete MC (Glans completely exposed) Evaluation of Training efficacy – Procedure time - first 125 subjects vs. last 125 subjects – Procedure related AEs – Pain assessment – Time to complete healing

Results

Demographics 590 adult male subjects Average age : 25 SD 4 5 HIV positive

Primary Endpoint: Safety AE Frequency (N=590) SeverityIncidence, 95% CI Device related2Moderate0.34% [0.04% %] Procedure related1Moderate0.17% [0.00% %] Unrelated to device or procedure 2Moderate0.34% [0.04% %] Total AEs5Moderate0.85% [0.28% %] No Severe AE, No Infection All AEs were easily resolved with minimal intervention

AEs Details Subj PrePex date DescriptionSeverity Device Related InterventionFollow up /07/11 Disturbance of urine flowModerateNo Re- placement Resolved 56 01/08/11 Pain VAS 10 at day 6ModerateYesSelf-removalResolved 56 02/08/11 Bleeding due to self-removal of foreskin ModerateNo Pressure on site Resolved /08/11 Moving of Elastic Ring by subject during masturbation ModerateNo Re- Placement Resolved /09/11 Bleeding post RemovalModerateYes1 sutureResolved

Efficacy 100% of subjects fully circumcised Subjects healed completely on average day 33 after device removal SD 6.79

Secondary Endpoint: MC time First 125 subjectsLast 125 subjects Procedure time (Placement + Removal) 4min 58sec SD 2min 46sec 2min 51sec SD 42sec Preparation time (Placement + Removal) 2min 48sec SD 1min 17sec 1min 48sec SD 46sec Total MC time (Procedure + Preparation) 7 min 46 sec SD 4min 3 sec 4min 39 sec SD 1min 26 sec

Side Effects Expected side effects include : Oozing Localized edema Clear exudate Expected Side Effects Number of cases (N=590) Percent of cases (N=590) Oozing18 3.0% Localized edema49 8.3% Clear exudate8 1.3% Total % No intervention required all side effects resolved naturally

Secondary Endpoint: Pain Assessment Visual Analogue Scale (VAS) was used in order to assess the subject’s pain level During Device placement (no anesthesia) within 1 hour after placement During erection with device Before device removal During removal After removal Average Pain 1 SD SD SD SD0.8 3 SD 1.9 (For 5 sec) 0.9 SD 1.3

Conclusions

AEs: Very low rate that demonstrates the high safety of PrePex MC when performed by nurses Training: Nurses with no prior knowledge, can be trained in 3 days course to perform Safe, Effective and Efficient MC, which is most suitable for scale up MC program

Scale up – Q Rwanda plans to initiate scale up program – 2 Million MCs in 2 years – 148 teams of 2 nurses – 54 procedures per team per day (Placement +Removal) – 4000 MCs Per day (4000 placements 4000 removals) – 250 working days per year MC Method – PrePex by nurses No injected anesthesia Bloodless procedure No sutures No sterile settings Safe and effective Next Steps

Thank You